We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Relay Therapeutics Inc
5 own
3 watching
Current Price
$21.56
$-0.51
(-2.31%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,604.69M
52-Week High
35.36
52-Week Low
12.65
Average Volume
0.84M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,604.69M52-Week High35.3652-Week Low12.65Average Volume0.84MDividend Yield--P/E Ratio--What does the Relay Therapeutics Inc do?
We are a clinical-stage precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. We were incorporated under the laws of the State of Delaware on May 4, 2015 under the name "Allostery, Inc." Our principal corporate office is located at 399 Binney Street, 2nd Floor, Cambridge, MA 02139, and our telephone number is (617) 370-8837. Our website address is www.relaytx.com.
Read More
How much money does Relay Therapeutics Inc make?
News & Events about Relay Therapeutics Inc.
Globe Newswire
1month ago
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to present at the 41st Annual J.P. ...
Ticker Report
1month ago
Relay Therapeutics, Inc. (NASDAQ:RLAY Get Rating) has received an average recommendation of Moderate Buy from the eight analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold...
Zolmax
4 months ago
Relay Therapeutics, Inc. (NASDAQ:RLAY Get Rating) shares gapped up before the market opened on Wednesday . The stock had previously closed at $23.29, but opened at $24.12. Relay Therapeutics shares last traded at $23.99, with a volume of 2,474 shares changing hands. Wall Street Analysts Forecast ...
Ticker Report
4 months ago
Relay Therapeutics, Inc. (NASDAQ:RLAY Get Rating) CEO Sanjiv Patel sold 14,000 shares of the firms stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $23.47, for a total value of $328,580.00. Following the transaction, the chief executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Relay Therapeutics Inc share price today?
Can Indians buy Relay Therapeutics Inc shares?
How can I buy Relay Therapeutics Inc shares from India?
Can Fractional shares of Relay Therapeutics Inc be purchased?
What are the documents required to start investing in Relay Therapeutics Inc stocks?
What is today’s traded volume of Relay Therapeutics Inc?
What is today’s market capitalisation of Relay Therapeutics Inc?
What is the 52-Week High and Low Range of Relay Therapeutics Inc?
What percentage is Relay Therapeutics Inc down from its 52-Week High?
What percentage is Relay Therapeutics Inc up from its 52-Week Low?
Current Price
$21.56
$-0.51
(-2.31%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.